Abu-Khalaf, Maysa M. https://orcid.org/0000-0003-4888-7547
Safonov, Anton
Stratton, Jamie
Wang, Shiyi
Hatzis, Christos
Park, Esther
Pusztai, Lajos
Gross, Cary P.
Russell, Raymond
Article History
Received: 21 January 2019
Accepted: 19 February 2019
First Online: 24 April 2019
Compliance with ethical standards
:
: Maysa M. Abu-Khalaf MD: Received honorarium for a Consultant/Advisory role from AstraZeneca, Immunomedics, PUMA, Biothera and Agendia. Received a research grant from Novartis for an investigator-initiated clinical trial. Christos Hatzis PhD: Received remuneration from Bristol-Myers Squibb. Lajos Pusztai MD DPhil: Received honorarium for a Consultant/Advisory role from Merck, Astrazeneca, Novartis, Seattle Genetics, Pfizer, and Almac: received research funding from Merck, AstraZeneca, and Seattle Genetics. Cary P. Gross MD: Received remuneration/Travel funding from Flatiron Health and received research funding from Johnson &Johnson and NCCN/Pfizer. Raymond Russell MD, PhD: Spouse employed by ResTORbio. Spouse receives stock options from ResTORbio. All other authors declared that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was waived by institutional review board for this retrospective review study.